| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1873-3468.12904 |
| P8608 | Fatcat ID | release_vetr2kvgsnb4zf6doxramftdky |
| P698 | PubMed publication ID | 29127710 |
| P50 | author | Rafael Moreno-Sanchez | Q57574778 |
| Emma Saavedra | Q104904996 | ||
| Citlali Vázquez | Q117254355 | ||
| Zabdi González-Chávez | Q117254358 | ||
| Marlen Mejia-Tlachi | Q117254360 | ||
| José Salud Rodríguez-Zavala | Q117254370 | ||
| P2093 | author name string | Aketzalli Silva | |
| P2860 | cites work | The human serum metabolome | Q21135549 |
| Leishmania trypanothione synthetase-amidase structure reveals a basis for regulation of conflicting synthetic and hydrolytic activities | Q24655332 | ||
| Protein production by auto-induction in high density shaking cultures | Q27860514 | ||
| Hgt1p, a high affinity glutathione transporter from the yeast Saccharomyces cerevisiae. | Q27933589 | ||
| The importance of glutathione in human disease | Q28180886 | ||
| AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility | Q29547658 | ||
| A semiempirical free energy force field with charge-based desolvation | Q29614316 | ||
| Glutathione transport: a new role for PfCRT in chloroquine resistance | Q30041670 | ||
| Protein structure homology modeling using SWISS-MODEL workspace. | Q30374281 | ||
| Genetic validation of Trypanosoma brucei glutathione synthetase as an essential enzyme | Q33766769 | ||
| Biologic and pharmacologic regulation of mammalian glutathione synthesis | Q33777922 | ||
| Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation | Q34228648 | ||
| Inhibition of glutathione synthesis as a chemotherapeutic strategy for trypanosomiasis | Q36344549 | ||
| Insights into the redox biology of Trypanosoma cruzi: Trypanothione metabolism and oxidant detoxification | Q37202974 | ||
| Metabolic control analysis: a tool for designing strategies to manipulate metabolic pathways. | Q37217309 | ||
| Targeting Trypanothione Metabolism in Trypanosomatid Human Parasites | Q37782110 | ||
| Glutathione transporters | Q38064620 | ||
| Key proteins in the polyamine-trypanothione pathway as drug targets against Trypanosoma cruzi | Q38164047 | ||
| Thiol redox biology of trypanosomatids and potential targets for chemotherapy | Q38642326 | ||
| Identification of protein complex associated with LYT1 of Trypanosoma cruzi | Q39468283 | ||
| Mitochondrial changes associated with glutathione deficiency | Q40437326 | ||
| Buthionine sulfoximine increases the toxicity of nifurtimox and benznidazole to Trypanosoma cruzi. | Q40734322 | ||
| Functional analysis of the intergenic regions of TcP2beta gene loci allowed the construction of an improved Trypanosoma cruzi expression vector | Q40919671 | ||
| Biological characterization and genetic diversity of Mexican isolates of Trypanosoma cruzi | Q41031344 | ||
| Gene knockdown of gamma-glutamylcysteine synthetase by RNAi in the parasitic protozoa Trypanosoma brucei demonstrates that it is an essential enzyme | Q44530879 | ||
| Characterization of Trypanosoma cruzi L-cysteine transport mechanisms and their adaptive regulation. | Q46143054 | ||
| Drug target validation of the trypanothione pathway enzymes through metabolic modelling | Q48051536 | ||
| On the discovery of glutathione. | Q52398273 | ||
| Role of glutathione in the susceptibility of Trypanosoma cruzi to drugs. | Q54367031 | ||
| Glutathione and trypanothione in several strains of Trypanosoma cruzi: Effect of drugs | Q58849682 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Trypanosoma cruzi | Q150162 |
| P304 | page(s) | 3881-3894 | |
| P577 | publication date | 2017-11-11 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Buthionine sulfoximine is a multitarget inhibitor of trypanothione synthesis in Trypanosoma cruzi | |
| P478 | volume | 591 |
Search more.